medigraphic.com
ISSN 1561-2988 (Print)

2013, Number 4

<< Back Next >>

Rev Cubana Farm 2013; 47 (4)

Drug prescription in hospitalized hypertensive elderly

García OM, Abreu VI, Ruíz SAK, Espinosa MJ, Salinas GTM

Language: Spanish
References: 20
Page: 475-482
PDF size: 58.30 Kb.


ABSTRACT

Objective: to analyze the prescriptions of antihypertensive drugs in hospitalized patients.
Methods: observational, descriptive and cross sectional study of drug utilization of indication prescription-type. Two hundred hypertensive aged patients were randomly selected from the total number of hospitalized individuals with this disease from January to December, 2009 in «Calixto Garcia» hospital. The primary response variable was the adequacy or not of the prescription.
Results: the most significant result was that 57 % of the sample was classified as stage II blood hypertension and 65 % were in the cardiovascular risk group C. In the study, 73.1 % of diabetic hypertensive patients were treated with diuretics and 14.9 % with beta blockers. Most of the renal insufficiency patients used angiotensin-converting enzyme inhibitors and diuretics (60.7 and 78.6 % respectively). Forty four percent of hypertensive patients were under monotherapy.
Conclusions: according to the risk stratification criteria and the associated comorbidity, it was found that management of pharmacological prescription in the studied group was inadequate.


REFERENCES

  1. Anuario Estadístico de Salud 2011. Dirección Nacional de Registros Médicos y Estadísticas de Salud. La Habana: MINSAP; 2012.

  2. Hutchison LC, O'Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Pract. 2007;20:4-12.

  3. Hilary J Hamilton, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatrics. 2009;9:5.

  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, et al. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.

  5. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension. 2007; 25:1105-87.

  6. Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123:2434-506.

  7. Aspectos epidemiológicos y sociales del envejecimiento. In: Mantenerse en forma para la vida. Washington DC: OPS; 2004.

  8. Oficina Nacional de Estadísticas Centro de Estudios de Población y Desarrollo 2009. El envejecimiento de la población. Cuba y sus territorios. La Habana: MINSAP; 2009.

  9. Case A. Paxon C. Sex differences in morbidity and mortality. Demography. 2005;42(2):189-214.

  10. Edward G. Lakatta. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises. Part II: The Aging Heart in Health: Links to Heart Disease. Circulation. 2003;107:346-54.

  11. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: A randomised, controlled trial. J Am Geriatr Soc. 2007;55:65865.

  12. Rosendorff C, Black HR, Cannon Christopher P. Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007;115;2761-88.

  13. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2009;3(Suppl1):S13-S61.

  14. Gérvas J. Comorbilidad. Boletín AES. 2008;(61):8-9.

  15. Miguel F, García F, Montero MJ. Tratamiento de la hipertensión arterial en los diabéticos: una revisión crítica. SEMERGEN. 2007;33:241-9.

  16. Scott E. Nelson. Management of patients with type 2 diabetes. Current Medical Research & Opinion. 2011;27(10):1931-47.

  17. Couchoud C, Moranne O, Frimat L, Labeeuw M, Allot V, Stengel B. Associations between comorbidities, treatment choice and outcome in the elderly with end stage renal disease. Nephrol Dial Transplant. 2007;22:3246-54.

  18. Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC). Guía europea de prevención cardiovascular en la práctica clínica. Adaptación española del CEIPC 2008. Rev Esp Salud Pública. 2008:82:581-16.

  19. Borrás Almenar C, Marí AA. Criterios, indicadores y estándares de calidad para el manejo de los medicamentos. En: Jiménez Torrez NV (editor). Calidad farmacoterapéutica. Barcelona: Publicación de la Universidad de Valencia; 2006. p. 229, 243.

  20. Petrovic M, Cobbaert K, Vander Stichele R. Assessing of medication prescribing quality in Belgian elderly care homes. Br J Clin Pharmacol. 2010;69(6):713.




2020     |     www.medigraphic.com